Regulus Therapeutics Inc. Annual Return On Equity in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Regulus Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2023.
  • Regulus Therapeutics Inc. Return On Equity for the quarter ending September 30, 2024 was -53.1 %, a 43.7% increase year-over-year.
  • Regulus Therapeutics Inc. annual Return On Equity for 2023 was -109 %, a 58.6% decline from 2022.
  • Regulus Therapeutics Inc. annual Return On Equity for 2022 was -68.8 %, a 8.46% increase from 2021.
  • Regulus Therapeutics Inc. annual Return On Equity for 2021 was -75.2 %, a 31.6% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -109 -40.4 -58.6% Jan 1, 2023 Dec 31, 2023
2022 -68.8 +6.36 +8.46% Jan 1, 2022 Dec 31, 2022
2021 -75.2 +34.7 +31.6% Jan 1, 2021 Dec 31, 2021
2020 -110 +291 +72.6% Jan 1, 2020 Dec 31, 2020
2019 -401 +270 +40.2% Jan 1, 2019 Dec 31, 2019
2018 -671 -469 -233% Jan 1, 2018 Dec 31, 2018
2017 -202 -101 -100% Jan 1, 2017 Dec 31, 2017
2016 -101 -58.8 -140% Jan 1, 2016 Dec 31, 2016
2015 -42.1 +17.5 +29.3% Jan 1, 2015 Dec 31, 2015
2014 -59.6 -34.1 -134% Jan 1, 2014 Dec 31, 2014
2013 -25.5 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.